BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1

Historical Institutional Holders from Q1 2014 to Q4 2018

All holders as of December 31, 2018
Q4 2018
Type / Class
Debt / NOTE 0.750%10/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2018 Q4 $0 $0 -$362M 0
2018 Q3 $350M $362M +$17.7M $1.03 35
2018 Q2 $330M $351M -$5.02M $1.06 48
2018 Q1 $334M $342M -$19.5M $1.02 43
2017 Q4 $339M $368M -$11.6M $1.08 42
2017 Q3 $349M $390M +$10.1M $1.12 43
2017 Q2 $340M $381M -$2.41M $1.11 47
2017 Q1 $340M $386M -$7.78M $1.13 41
2016 Q4 $354M $404M -$18.5M $1.12 40
2016 Q3 $374M $450M +$21M $1.20 42
2016 Q2 $351M $411M -$2.63B $1.11 45
2016 Q1 $379M $438M +$17.8M $1.16 48
2015 Q4 $367M $473M -$7.64M $1.29 42
2015 Q3 $364M $474M -$16.8M $1.29 53
2015 Q2 $360M $558M -$1.2B $1.54 53
2015 Q1 $311M $463M +$55.1M $1.49 49
2014 Q4 $277M $328M -$819M $1.18 45
2014 Q3 $324M $345M +$446K $1.06 46
2014 Q2 $321M $333M +$53.2M $1.03 43
2014 Q1 $240M $264M -$16.5M $1.10 34